Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 3,773 | 4,124 | 4,418 | 4,250 | 3,986 |
| Cost of Goods | 634 | 595 | 701 | 682 | 660 |
| Gross Profit | 3,140 | 3,529 | 3,717 | 3,569 | 3,326 |
| Operating Expenses | 28,490 | 25,805 | 19,250 | 24,080 | 25,272 |
| Operating Income | -24,716 | -21,681 | -14,832 | -19,830 | -21,286 |
| Other Income | 315 | 253 | 167 | 153 | 130 |
| Pre-tax Income | -24,402 | -21,427 | -14,665 | -19,677 | -21,157 |
| Net Income Continuous | -24,402 | -21,427 | -14,665 | -19,677 | -21,157 |
| Net Income | $-24,402 | $-21,427 | $-14,665 | $-19,677 | $-21,157 |
| EPS Basic Total Ops | -5.50 | -4.50 | -3.50 | -5.00 | -5.50 |
| EPS Basic Continuous Ops | -5.63 | -5.00 | -3.53 | -4.84 | -5.35 |
| EPS Diluted Total Ops | -5.50 | -4.50 | -3.50 | -5.00 | -5.50 |
| EPS Diluted Continuous Ops | -5.63 | -5.00 | -3.53 | -4.84 | -5.35 |
| EBITDA(a) | $-24,657 | $-21,625 | $-14,778 | $-19,777 | $-21,237 |